Aspirin Better at Clot Prevention, Study Finds
From Times Wire Reports
Aspirin was cheaper and more effective than the popular prescription drug ticlopidine at preventing stroke-producing blood clots from forming, a study of at-risk blacks said.
The six-year study of 1,809 black men and women who previously suffered a stroke found 12% of those who took aspirin had a recurrent stroke, heart attack, or died from a vascular problem, compared with nearly 15% of those taking ticlopidine.
The results, published in the Journal of the American Medical Assn., did not necessarily translate to other races, study author Philip Gorelick of Rush Medical College in Chicago said.
